According to Gilead Sciences's latest financial reports the company's current earnings are $28.73 Billion USD. In 2024 the company made an earning of $0.69 Billion USD a decrease over its 2023 earnings that were of $6.85 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | $6.82 B | 889.13% |
2024 | $0.69 B | -89.94% |
2023 | $6.85 B | 17.97% |
2022 | $5.81 B | -29.77% |
2021 | $8.27 B | 395.99% |
2020 | $1.66 B | -67.66% |
2019 | $5.16 B | -33.84% |
2018 | $7.79 B | -42.35% |
2017 | $13.52 B | -20.87% |
2016 | $17.09 B | -21.06% |
2015 | $21.65 B | 45.8% |
2014 | $14.85 B | 253.01% |
2013 | $4.20 B | 16.51% |
2012 | $3.61 B | -1.07% |
2011 | $3.65 B | -6.71% |
2010 | $3.91 B | 11.75% |
2009 | $3.50 B | 29.5% |
2008 | $2.70 B | 19.11% |
2007 | $2.27 B | -455.74% |
2006 | -$0.64 Billion | -154.93% |
2005 | $1.16 B | 76.99% |
2004 | $0.65 B | -266.16% |
2003 | -$0.4 Billion | -638.24% |
2002 | $73.39 M | 31.5% |
2001 | $55.81 M | -242.15% |
2000 | -$39.27 Million | -40.2% |
1999 | -$65.67 Million | 31.85% |
1998 | -$49.8 Million | 8.73% |
1997 | -$45.8 Million | 27.22% |
1996 | -$36 Million |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Amgen AMGN | $6.65 B | -2.56% | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | -$0.28 Billion | -104.06% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $3.62 B | -46.93% | ๐บ๐ธ USA |
![]() Illumina ILMN | -$0.79 Billion | -111.44% | ๐บ๐ธ USA |
![]() Biogen BIIB | $1.75 B | -74.32% | ๐บ๐ธ USA |
![]() Pfizer PFE | $10.34 B | 51.52% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | $27.40 B | 301.58% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $13.60 B | 99.27% | ๐บ๐ธ USA |
![]() Merck MRK | $21.45 B | 214.29% | ๐บ๐ธ USA |